1. Overexpression of long non-coding RNA GHET1 promotes the development of multidrug resistance in gastric cancer cells.

Biomed. Pharmacother., 2017, 92 p. 5

DOI: S0753-3322(17)30631-5

Citations as recorded by:

2. Long Non-Coding RNAs: Key Regulators of Epithelial-Mesenchymal Transition, Tumour Drug Resistance and Cancer Stem Cells

Cancers, 2017, 9(4) p. 38

DOI: 10.3390/cancers9040038

Citations as recorded by:

3. LncRNA plasmacytoma variant translocation 1 is an oncogene in bladder urothelial carcinoma

Oncotarget, 2017, 8 p. 64273

DOI: 10.18632/oncotarget.19604

Citations as recorded by:

4. LncRNA UCA1 in anti-cancer drug resistance

Oncotarget, 2017, 8 p. 64638

DOI: 10.18632/oncotarget.18344

Citations as recorded by:

5. The prognostic significance of UCA1 for predicting clinical outcome in patients with digestive system malignancies

Oncotarget, 2017, 8 p. 40620

DOI: 10.18632/oncotarget.16534

Citations as recorded by:

6. Long non-coding RNA tumor suppressor candidate 7 advances chemotherapy sensitivity of endometrial carcinoma through targeted silencing of miR-23b

Tumour Biol., 2017, 39(6) p. 101042831770788

DOI: 10.1177/1010428317707883

Citations as recorded by:

7. Plasma Long Noncoding RNA Urothelial Carcinoma Associated 1 Predicts Poor Prognosis in Chronic Heart Failure Patients

Med Sci Monit, 2017, 23 p. 2226

DOI: 10.12659/MSM.904113

Citations as recorded by:

8. GNB2L1 and its O-GlcNAcylation regulates metastasis via modulating epithelial-mesenchymal transition in the chemoresistance of gastric cancer

PLoS ONE, 2017, 12(8) p. e0182696

DOI: 10.1371/journal.pone.0182696

Citations as recorded by:

9. Novel Implications of Exosomes and lncRNAs in the Diagnosis and Treatment of Pancreatic Cancer

Year: 2017

Citations as recorded by: